This is a Validated Antibody Database (VAD) review about mouse Cdkn1b, based on 142 published articles (read how Labome selects the articles), using Cdkn1b antibody in all methods. It is aimed to help Labome visitors find the most suited Cdkn1b antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cdkn1b synonym: AA408329; AI843786; Kip1; p27; p27Kip1

Knockout validation
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; human; fig s1a
Cell Signaling Technology Cdkn1b antibody (CST, 2552) was used in western blot knockout validation on human samples (fig s1a). Nat Cell Biol (2021) ncbi
BD Biosciences
mouse monoclonal (57/Kip1/p27)
  • western blot knockout validation; rat; 1:1000; loading ...; fig s1d
BD Biosciences Cdkn1b antibody (BD, 610241) was used in western blot knockout validation on rat samples at 1:1000 (fig s1d). PLoS Genet (2019) ncbi
BD Biosciences
mouse monoclonal (57/Kip1/p27)
  • western blot knockout validation; mouse; fig 2
BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610242) was used in western blot knockout validation on mouse samples (fig 2). Nucleic Acids Res (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-8)
  • western blot; human; 1:200; loading ...
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on human samples at 1:200. Int J Mol Sci (2022) ncbi
mouse monoclonal (A-10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4b
  • immunocytochemistry; human; loading ...; fig 5a
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-393380) was used in immunohistochemistry - paraffin section on human samples (fig 4b), in immunocytochemistry on human samples (fig 5a) and in western blot on human samples (fig 4a). Front Oncol (2022) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on human samples (fig 2b). Int J Mol Sci (2021) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:1000; loading ...; fig 1g
Santa Cruz Biotechnology Cdkn1b antibody (Santa, sc1641) was used in western blot on human samples at 1:1000 (fig 1g). Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (F-8)
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz Biotechnology, sc-1641) was used . Cell Death Dis (2021) ncbi
mouse monoclonal (F-8)
  • immunohistochemistry; mouse; 1:600; loading ...
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc1641) was used in immunohistochemistry on mouse samples at 1:600. Nat Commun (2021) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; 1:500; fig 5a
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on mouse samples at 1:500 (fig 5a). J Cell Mol Med (2021) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; loading ...; fig 4d
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on mouse samples (fig 4d). Biol Open (2021) ncbi
mouse monoclonal (DCS-72)
  • western blot; human; loading ...; fig 1f
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-56338) was used in western blot on human samples (fig 1f). Oncogene (2019) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; fig 2e
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz Biotechnology, sc-1641) was used in western blot on mouse samples (fig 2e). Cell (2018) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 5c
Santa Cruz Biotechnology Cdkn1b antibody (SantaCruz, sc-1641) was used in western blot on human samples (fig 5c). Oncogene (2017) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; loading ...; fig 6b
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz Biotechnology, sc-1641) was used in western blot on mouse samples (fig 6b). Stem Cells Int (2017) ncbi
mouse monoclonal (SX53G8.5)
  • immunocytochemistry; human; loading ...; fig 2S1A
  • immunocytochemistry; mouse; loading ...; fig 2A
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-53871) was used in immunocytochemistry on human samples (fig 2S1A) and in immunocytochemistry on mouse samples (fig 2A). elife (2017) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 1B
  • western blot; mouse; loading ...; fig 1B
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on human samples (fig 1B) and in western blot on mouse samples (fig 1B). elife (2017) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on human samples (fig 2c). Oncotarget (2017) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig s2c
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on human samples (fig s2c). J Mol Med (Berl) (2016) ncbi
mouse monoclonal (DCS-72)
  • western blot; rat; 1:250; fig 4
In order to study the correlation between glutamate-induced neurotoxicity and expression of cell cycle proteins in cortical neurons, Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc--56338) was used in western blot on rat samples at 1:250 (fig 4). Biofactors (2016) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; 1:100; fig 7
  • western blot; human; 1:100; fig 7
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on mouse samples at 1:100 (fig 7) and in western blot on human samples at 1:100 (fig 7). Oncotarget (2016) ncbi
mouse monoclonal (F-8)
  • western blot; rat; 1:500; fig 3
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, SC1641) was used in western blot on rat samples at 1:500 (fig 3). Int J Mol Med (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig s4g
Santa Cruz Biotechnology Cdkn1b antibody (Santa, sc-1641) was used in western blot on human samples (fig s4g). Nature (2015) ncbi
mouse monoclonal (DCS-72)
  • immunocytochemistry; human
  • western blot; human; 1:500
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-56338) was used in immunocytochemistry on human samples and in western blot on human samples at 1:500. Asian Pac J Cancer Prev (2014) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; fig 4f
In order to study the role of N-terminal acetylation in Ogden syndrome, Santa Cruz Biotechnology Cdkn1b antibody (Santa, sc-53871) was used in western blot on human samples (fig 4f). Hum Mol Genet (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 5
Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in western blot on human samples (fig 5). Oncotarget (2014) ncbi
mouse monoclonal (F-8)
  • immunohistochemistry - paraffin section; mouse; 1:50
In order to test if Brca1 loss in mammary epithelium alters the estrogenic growth response and if exposure to increased estrogen or ERalpha correlates with Brca1 deficiency, Santa Cruz Biotechnology Cdkn1b antibody (Santa Cruz, sc-1641) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. Oncogene (2008) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5c
Invitrogen Cdkn1b antibody (Invitrogen, 346300) was used in western blot on human samples (fig 5c). Front Oncol (2022) ncbi
mouse monoclonal (DCS-72.F6)
  • immunohistochemistry; mouse; 1:100; fig 5b
Invitrogen Cdkn1b antibody (NeoMarkers, MS-256-P1) was used in immunohistochemistry on mouse samples at 1:100 (fig 5b). Nat Commun (2017) ncbi
mouse monoclonal (DCS-72.F6)
  • western blot; human; 1:500; fig 2
In order to elucidate the affect of p38 MAPK-mediated regulation of NB69 cell proliferation implication of free radicals by power frequency magnetic fields, Invitrogen Cdkn1b antibody (BioSource, AHZ0452) was used in western blot on human samples at 1:500 (fig 2). Int J Mol Sci (2016) ncbi
mouse monoclonal (DCS-72.F6)
  • immunocytochemistry; mouse; 1:200; fig 5
In order to analyze promotion of inner ear hair cells in mouse embryonic stem cells in vitro, Invitrogen Cdkn1b antibody (Biosource, AHZ0452) was used in immunocytochemistry on mouse samples at 1:200 (fig 5). Methods Mol Biol (2016) ncbi
domestic rabbit polyclonal
In order to study MARCKS signaling and how it expresses endothelial cell proliferation and vascular smooth muscle through a KIS-, p27kip1- dependent mechanism, Invitrogen Cdkn1b antibody (Invitrogen, 346300) was used . PLoS ONE (2015) ncbi
mouse monoclonal (DCS-72.F6)
  • immunohistochemistry; mouse; 1:200
In order to elucidate the molecular mechanisms involved in the timing and coordination of auditory prosensory proliferation and differentiation, Invitrogen Cdkn1b antibody (NeoMarkers/Thermo, MS-256-P1) was used in immunohistochemistry on mouse samples at 1:200. Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit polyclonal
In order to determine tissue specific functions of DLL1 or DLL4 using transgenic mice, Invitrogen Cdkn1b antibody (NeoMarkers, PA5-27188) was used . PLoS Genet (2015) ncbi
mouse monoclonal (DCS-72.F6)
  • western blot; human; 1:200
In order to study kinases involved in H2AX phosphorylation in irradiated human keratinocytes, Invitrogen Cdkn1b antibody (Invitrogen, AHZ0452) was used in western blot on human samples at 1:200. Cell Mol Life Sci (2015) ncbi
mouse monoclonal (DCS-72.F6)
  • western blot; mouse; fig 1
In order to explore the contributions of hyperglycemia and p27(kip1) suppression on islet beta cell regeneration, Invitrogen Cdkn1b antibody (Thermo Fisher Scientific, DCS-72.F6) was used in western blot on mouse samples (fig 1). Int J Endocrinol (2012) ncbi
mouse monoclonal (DCS-72.F6)
  • immunohistochemistry - paraffin section; human; 1:40
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen Cdkn1b antibody (Lab Vision, MS-256) was used in immunohistochemistry - paraffin section on human samples at 1:40. Int J Oncol (2012) ncbi
mouse monoclonal (DCS-72.F6)
  • immunohistochemistry - paraffin section; mouse; fig 2
In order to determine the role of Shp2 in brain development, Invitrogen Cdkn1b antibody (Biosource, AHZ0452) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Dev Biol (2009) ncbi
mouse monoclonal (DCS-72.F6)
In order to study if the growth state-dependent tyrosine phosphorylation of p27Kip1 determines whether or not it inhibits cdk4, Invitrogen Cdkn1b antibody (NeoMarkers, DCS-72.F6) was used . Mol Cell Biol (2008) ncbi
mouse monoclonal (DCS-72.F6)
  • western blot; human; fig 7
In order to elucidate how PTEN reduces proliferation without cell cycle arrest in T cells, Invitrogen Cdkn1b antibody (Biosource, DCS-72.F6) was used in western blot on human samples (fig 7). Oncogene (2003) ncbi
Abcam
mouse monoclonal (SX53G8)
  • immunohistochemistry; mouse; 1:150; loading ...; fig 4c
Abcam Cdkn1b antibody (Abcam, ab193379) was used in immunohistochemistry on mouse samples at 1:150 (fig 4c). Technol Cancer Res Treat (2022) ncbi
domestic rabbit monoclonal (EP233(2)Y)
  • immunohistochemistry; mouse; loading ...; fig s4c
Abcam Cdkn1b antibody (Abcam, ab62364) was used in immunohistochemistry on mouse samples (fig s4c). Nature (2019) ncbi
mouse monoclonal (SX53G8)
  • western blot; human; loading ...; fig 5a
Abcam Cdkn1b antibody (Abcam, ab193379) was used in western blot on human samples (fig 5a). J Mol Neurosci (2018) ncbi
domestic rabbit monoclonal
  • western blot; human; 1:500; fig 4
Abcam Cdkn1b antibody (Abcam, ab92741) was used in western blot on human samples at 1:500 (fig 4). Biol Open (2016) ncbi
domestic rabbit monoclonal (EP233(2)Y)
  • western blot; human; fig 4
Abcam Cdkn1b antibody (Abcam, ab62364) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP233(2)Y)
  • western blot; human; 1:1000; fig 1
In order to study tyrosine autophosphorylation in members of the homeodomain interacting protein kinase family, Abcam Cdkn1b antibody (Abcam, ab62364) was used in western blot on human samples at 1:1000 (fig 1). Cell Commun Signal (2015) ncbi
Cell Signaling Technology
mouse monoclonal (SX53G8.5)
  • western blot; mouse; 1:1000; loading ...; fig 6f
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, 3698) was used in western blot on mouse samples at 1:1000 (fig 6f). elife (2022) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; mouse; 1:1000; loading ...; fig 3f
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, 3698) was used in western blot on mouse samples at 1:1000 (fig 3f). PLoS ONE (2021) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; human; fig s1a
Cell Signaling Technology Cdkn1b antibody (CST, 2552) was used in western blot knockout validation on human samples (fig s1a). Nat Cell Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3e
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, #2552) was used in western blot on mouse samples at 1:1000 (fig 3e). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; mouse; loading ...; fig 3b
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, 3688) was used in western blot on mouse samples (fig 3b). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1h
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, 2552) was used in western blot on human samples (fig 1h). Nature (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6d
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552S) was used in western blot on human samples at 1:1000 (fig 6d). Science (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; chicken; 1:500; loading ...; fig 2k
Cell Signaling Technology Cdkn1b antibody (Cell Signalling Technology, 2552) was used in immunohistochemistry - frozen section on chicken samples at 1:500 (fig 2k). elife (2019) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Cdkn1b antibody (cell signaling technologies, 3698) was used in western blot on human samples (fig 5c). Front Genet (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology Cdkn1b antibody (CST, 2552) was used in western blot on human samples (fig 1e). Cell Rep (2019) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; mouse; 1:100; loading ...; fig 4m
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3688) was used in western blot on mouse samples at 1:100 (fig 4m). Mol Psychiatry (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on human samples (fig 2b). Cancer Chemother Pharmacol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4a
  • immunohistochemistry; mouse; loading ...; fig 2a
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, 2552) was used in western blot on human samples at 1:1000 (fig 4a) and in immunohistochemistry on mouse samples (fig 2a). Oncogene (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3b
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, 2552) was used in western blot on mouse samples at 1:1000 (fig 3b). Cancer Discov (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2g
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on human samples (fig 2g). Oncogene (2017) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; human; 1:1000; fig 4a
Cell Signaling Technology Cdkn1b antibody (Cell Signaling Technology, D37H1) was used in western blot on human samples at 1:1000 (fig 4a). Immun Inflamm Dis (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4b
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on mouse samples (fig 4b). Basic Res Cardiol (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology Cdkn1b antibody (CST, 2552) was used in western blot on mouse samples (fig 4b). PLoS ONE (2017) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3698) was used in western blot on human samples at 1:1000 (fig 5a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; human; 1:1000; loading ...; fig 2c
In order to identify and characterize an inhibitor of the COP9 signalosome, Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3688) was used in western blot on human samples at 1:1000 (fig 2c). Nat Commun (2016) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3698) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; human; 1:1000; fig 1
  • western blot; mouse; 1:1000; fig s1
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3688) was used in western blot on human samples at 1:1000 (fig 1) and in western blot on mouse samples at 1:1000 (fig s1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; human; 1:1000; loading ...; fig s3b
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3688) was used in western blot on human samples at 1:1000 (fig s3b). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6h
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on human samples (fig 6h). Cell Death Discov (2016) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3698) was used in western blot on human samples (fig 4b). Nat Struct Mol Biol (2016) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology Cdkn1b antibody (Cell signaling, 3688) was used in western blot on human samples at 1:1000 (fig s1). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
In order to study the role of Skp2 in paclitaxel-resistant prostate cancer cells, Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on human samples (fig 1d). Oncol Rep (2016) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; mouse; 1:1000; loading ...; fig s10a
In order to use naked mole-rat-induced pluripotent stem cells to study mechanisms of cancer resistance, Cell Signaling Technology Cdkn1b antibody (CST, 3,698) was used in western blot on mouse samples at 1:1000 (fig s10a). Nat Commun (2016) ncbi
mouse monoclonal (SX53G8.5)
  • immunocytochemistry; mouse; 1:200; fig 3
  • western blot; mouse; 1:1000; fig 3
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3698) was used in immunocytochemistry on mouse samples at 1:200 (fig 3) and in western blot on mouse samples at 1:1000 (fig 3). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; human; fig s1
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3688) was used in western blot on human samples (fig s1). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; mouse; 1:1000; fig 5
Cell Signaling Technology Cdkn1b antibody (CST, 3688) was used in western blot on mouse samples at 1:1000 (fig 5). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1). BMC Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3b
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on human samples (fig 3b). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7a
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on human samples (fig 7a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to analyze AMOTL1 and how it is antagonized by Merlin and promotes breast cancer progression, Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 2552) was used in western blot on human samples . Neoplasia (2016) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; mouse; 1:2000; loading ...; fig s4b
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, Cell Signaling Technology Cdkn1b antibody (Cell Signaling, SX53G8.5) was used in western blot on mouse samples at 1:2000 (fig s4b). Nat Commun (2016) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; loading ...; fig 2b
In order to study the role of polo-like kinase 1 in essential functions of alloreactive T cells, Cell Signaling Technology Cdkn1b antibody (Cell signaling, SX53G8.5) was used in western blot on human samples (fig 2b). Immunol Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology Cdkn1b antibody (Cell Signalling Technology, 2552S) was used in western blot on human samples (fig 4f). Oncotarget (2016) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; fig 4
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3698) was used in western blot on human samples (fig 4). Drug Des Devel Ther (2015) ncbi
domestic rabbit monoclonal (D37H1)
  • western blot; human; 1:1000; loading ...; fig 4A
Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3688) was used in western blot on human samples at 1:1000 (fig 4A). Mol Med Rep (2015) ncbi
mouse monoclonal (SX53G8.5)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Cdkn1b antibody (Cell signaling, SX53G8.5) was used in western blot on human samples (fig 3c). Mol Pharm (2015) ncbi
mouse monoclonal (SX53G8.5)
  • immunocytochemistry; human; 1:1000
In order to examine centriole behavior after DNA damage in synchronized untransformed human cells, Cell Signaling Technology Cdkn1b antibody (Cell Signaling, 3698) was used in immunocytochemistry on human samples at 1:1000. J Cell Physiol (2014) ncbi
BD Biosciences
mouse monoclonal (G173-524)
  • western blot; human; 1:500; loading ...; fig 1e
BD Biosciences Cdkn1b antibody (BD Biosciences, 554069) was used in western blot on human samples at 1:500 (fig 1e). EMBO J (2022) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry; mouse; 1:200; loading ...
BD Biosciences Cdkn1b antibody (BD, 610242) was used in immunohistochemistry on mouse samples at 1:200. Nat Commun (2021) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; loading ...; fig 3d
BD Biosciences Cdkn1b antibody (BD Biosciences, 610242) was used in western blot on mouse samples (fig 3d). Cell Death Discov (2021) ncbi
mouse monoclonal (57/Kip1/p27)
  • flow cytometry; human; 1:250; loading ...; fig s5d
BD Biosciences Cdkn1b antibody (BD Biosciences, 610242) was used in flow cytometry on human samples at 1:250 (fig s5d). Science (2020) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry; human; fig 2g
  • western blot; human; loading ...; fig 2e
BD Biosciences Cdkn1b antibody (BD Biosciences, 610242) was used in immunohistochemistry on human samples (fig 2g) and in western blot on human samples (fig 2e). Cancer Cell (2019) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry; mouse; loading ...; fig s4c
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in immunohistochemistry on mouse samples (fig s4c). Nature (2019) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3b
BD Biosciences Cdkn1b antibody (BD Pharmingen, 610241) was used in immunohistochemistry on mouse samples at 1:500 (fig 3b). elife (2019) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot knockout validation; rat; 1:1000; loading ...; fig s1d
BD Biosciences Cdkn1b antibody (BD, 610241) was used in western blot knockout validation on rat samples at 1:1000 (fig s1d). PLoS Genet (2019) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry; mouse; loading ...; fig 2c
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in immunohistochemistry on mouse samples (fig 2c). J Neurosci (2019) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; loading ...; fig 2c
BD Biosciences Cdkn1b antibody (BD, 610241) was used in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 1d
  • immunocytochemistry; mouse; 1:500; fig s8b
In order to explore the role of chromodomain helicase DNA-binding protein 7 in CHARGE syndrome, BD Biosciences Cdkn1b antibody (BD bioscience, 610241) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1d) and in immunocytochemistry on mouse samples at 1:500 (fig s8b). Nat Commun (2017) ncbi
mouse monoclonal (G173-524)
  • western blot; human; 1:2000; loading ...; fig 3g
BD Biosciences Cdkn1b antibody (BD Pharmingen, 554069) was used in western blot on human samples at 1:2000 (fig 3g). Nat Commun (2017) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; loading ...; fig 1d
BD Biosciences Cdkn1b antibody (BD Biosciences, 616242) was used in western blot on human samples (fig 1d). Mol Cancer Ther (2017) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 2h
BD Biosciences Cdkn1b antibody (BD Biosciences, 610242) was used in western blot on human samples (fig 2h). Nat Med (2017) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...
In order to propose a tumor-suppressive activity for macrophage migration inhibitory factor in murine skin, BD Biosciences Cdkn1b antibody (Becton Dickinson, 57) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. FASEB J (2017) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; 1:500; loading ...; fig 9a
In order to report the effects of valproic acid exposure in utero, BD Biosciences Cdkn1b antibody (Becton Dickinson, 610241) was used in western blot on mouse samples at 1:500 (fig 9a). J Neurosci (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 1:1000; loading ...; fig 3d
In order to elucidate the contribution of MDM2 expression to retinoblastoma tumorigenesis, BD Biosciences Cdkn1b antibody (Becton Dickenson, 610241) was used in western blot on human samples at 1:1000 (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 0.5 ug/ml; loading ...; fig 3B
BD Biosciences Cdkn1b antibody (BD, 610242) was used in western blot on human samples at 0.5 ug/ml (fig 3B). J Cell Biol (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; loading ...; fig 2k
In order to demonstrate that cyclin A2 regulates erythrocyte morphology and numbers, BD Biosciences Cdkn1b antibody (BD Transduction, 610242) was used in western blot on mouse samples (fig 2k). Cell Cycle (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 1:2000; loading ...; fig 2c
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in western blot on human samples at 1:2000 (fig 2c). Oncotarget (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 3
In order to investigate evidence for two distinct pathogenetic pathways by studing the squamous cell carcinoma of the oral cavity and cytokeratin and protein expression patterns, BD Biosciences Cdkn1b antibody (BD TL, 610241) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 3). Oncol Lett (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 5
In order to assess regulation of the small muscle protein, X-linked (SMPX) and myotube differentiation by the nuclear receptor NOR-1, BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610242) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 5
BD Biosciences Cdkn1b antibody (BD, 610242) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; 1:1000; loading ...; fig 6e
In order to show that Rb1 and Skp2 deletions are synthetic lethal and explore how this lethal relationship can be circumvented, BD Biosciences Cdkn1b antibody (BD Transduction Lab, 610242) was used in western blot on mouse samples at 1:1000 (fig 6e). J Biol Chem (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 1:1000; fig 1
In order to investigate activation of APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth by TGF-beta, BD Biosciences Cdkn1b antibody (BD Biosciences, BDB610242) was used in western blot on human samples at 1:1000 (fig 1). Cell Cycle (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 6
In order to characterize multiple molecularly defined cancer indications by studying ROS1, ALK inhibitor, Entrectinib, a Pan-TRK activity, BD Biosciences Cdkn1b antibody (BD Biosciences, 610242) was used in western blot on human samples (fig 6). Mol Cancer Ther (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 1
In order to investigate proteolytic processing of p27, BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610242) was used in western blot on human samples (fig 1). Oncogene (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig S1B
BD Biosciences Cdkn1b antibody (BD, 610241) was used in western blot on human samples (fig S1B). PLoS ONE (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - frozen section; mouse; fig 1
  • western blot; mouse; 1:2000; fig 1
  • western blot; human; 1:2000; fig 4
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in immunohistochemistry - frozen section on mouse samples (fig 1), in western blot on mouse samples at 1:2000 (fig 1) and in western blot on human samples at 1:2000 (fig 4). FASEB J (2016) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 1:1000; fig 1
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in western blot on human samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human
In order to study the effect of neddylation on COP9-Signalosome deneddylase activity, BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610242) was used in western blot on human samples . Cell Div (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 1:500; fig 1
BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610241) was used in western blot on human samples at 1:500 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot knockout validation; mouse; fig 2
BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610242) was used in western blot knockout validation on mouse samples (fig 2). Nucleic Acids Res (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - frozen section; mouse; 1:1000; fig 1
In order to develop a CRISPR/Cas9-mediated method for somatic gene disruption, BD Biosciences Cdkn1b antibody (BD Biosciences, 610242) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (G173-524)
  • western blot; mouse; fig 9a
BD Biosciences Cdkn1b antibody (BD, 554069) was used in western blot on mouse samples (fig 9a). J Cell Biol (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 1
BD Biosciences Cdkn1b antibody (BD bioscience, 610241) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 1:1000
In order to study the contribution of the Skp2-mH2A1-CDK8 axis to breast cancer, BD Biosciences Cdkn1b antibody (InBD Transduction Lab, 610241) was used in western blot on human samples at 1:1000. Nat Commun (2015) ncbi
mouse monoclonal (G173-524)
  • western blot; human
In order to determine the role of PCTAIRE1 in apoptosis, BD Biosciences Cdkn1b antibody (BD Pharmagen, G173-524) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 2
BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610241) was used in western blot on human samples (fig 2). Pigment Cell Melanoma Res (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry; mouse; 1:300
In order to investigate the role of Fgf10 in the development of the vertebrate inner ear, BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in immunohistochemistry on mouse samples at 1:300. Dev Biol (2015) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse
In order to identify the mechanistic link between Cullin neddylation and Myc ubiquitination/degradation, BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610241) was used in western blot on mouse samples . Nat Commun (2014) ncbi
mouse monoclonal (G173-524)
  • western blot; human; fig s6
BD Biosciences Cdkn1b antibody (BD Biosciences, 554069) was used in western blot on human samples (fig s6). Nat Commun (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse
BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610241) was used in western blot on mouse samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (G173-524)
  • immunocytochemistry; human
  • western blot; human
In order to identify the role of PCTAIRE1 in cancer cells, BD Biosciences Cdkn1b antibody (BD, G173-524) was used in immunocytochemistry on human samples and in western blot on human samples . Cancer Res (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; 1:1000; fig 8
In order to elucidate the molecular mechanisms of dilation formation and nuclear elongation, BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in western blot on mouse samples at 1:1000 (fig 8). Development (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human
BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610242) was used in western blot on human samples . BMC Cancer (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human
BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610241) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; 1:1000
In order to investigate the effect of epidermal growth factor on Skp2/Cks1 and p27kip1 in human extrahepatic cholangiocarcinoma cells, BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in western blot on human samples at 1:1000. World J Gastroenterol (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in western blot on human samples . Cell Death Differ (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; 1:1000
BD Biosciences Cdkn1b antibody (Becton Dickinson, 610242) was used in western blot on mouse samples at 1:1000. Genes Dev (2013) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in western blot on mouse samples . Cell Death Differ (2013) ncbi
mouse monoclonal (G173-524)
  • western blot; human; fig s2
In order to investigate the function of ING4 in normal, non-transformed primary fibroblasts, BD Biosciences Cdkn1b antibody (BD, 554069) was used in western blot on human samples (fig s2). Oncogene (2014) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - frozen section; chicken; 1:200
BD Biosciences Cdkn1b antibody (BD Transduction Labs, 610241) was used in immunohistochemistry - frozen section on chicken samples at 1:200. PLoS ONE (2013) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human
In order to investigate the effect of cyclin E1 and E2 on genomic instability, BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610241) was used in western blot on human samples . Cell Cycle (2013) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - paraffin section; mouse; 0.5 ug/ml
BD Biosciences Cdkn1b antibody (BD Transduction, 610242) was used in immunohistochemistry - paraffin section on mouse samples at 0.5 ug/ml. Hum Reprod (2013) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; fig 4
BD Biosciences Cdkn1b antibody (BD Transduction, 610242) was used in western blot on mouse samples (fig 4). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; human; fig 7
BD Biosciences Cdkn1b antibody (BD Biosciences, 61041) was used in western blot on human samples (fig 7). Oncogene (2012) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse
In order to study the role in Cdk regulation of the novel gene magoh identified in a genetic screen of a murine cell cycle mutant, BD Biosciences Cdkn1b antibody (BD Transduction Laboratories, 610241) was used in western blot on mouse samples . Genes Cells (2011) ncbi
mouse monoclonal (57/Kip1/p27)
  • western blot; mouse; 1:500
BD Biosciences Cdkn1b antibody (BD Biosciences, 610241) was used in western blot on mouse samples at 1:500. J Comp Neurol (2010) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry - frozen section; mouse; 1:100
BD Biosciences Cdkn1b antibody (BD Transduction Labs, 610241) was used in immunohistochemistry - frozen section on mouse samples at 1:100. J Comp Neurol (2008) ncbi
mouse monoclonal (57/Kip1/p27)
  • immunohistochemistry; mouse; 1:200
BD Biosciences Cdkn1b antibody (BD Transduction, 610241) was used in immunohistochemistry on mouse samples at 1:200. J Comp Neurol (2007) ncbi
Articles Reviewed
  1. Aboouf M, Armbruster J, Thiersch M, Guscetti F, Kristiansen G, Schraml P, et al. Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells. Int J Mol Sci. 2022;23: pubmed publisher
  2. Zhao M, Banhos Danneskiold Sams xf8 e N, Uličná L, Nguyen Q, Voilquin L, Lee D, et al. Phosphoproteomic mapping reveals distinct signaling actions and activation of muscle protein synthesis by Isthmin-1. elife. 2022;11: pubmed publisher
  3. Tao M, Ma H, Fu X, Wang C, Li Y, Hu X, et al. Semaphorin 3F induces colorectal cancer cell chemosensitivity by promoting P27 nuclear export. Front Oncol. 2022;12:899927 pubmed publisher
  4. Paulmann C, Spallek R, Karpiuk O, Heider M, Sch xe4 ffer I, Zecha J, et al. The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. EMBO J. 2022;41:e110871 pubmed publisher
  5. Jiang Z, Hong J, Zhang J, Wang X, Ma Y, Xiong Z, et al. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with p53 Deficiency. Technol Cancer Res Treat. 2022;21:15330338221119745 pubmed publisher
  6. Hsu H, Chen H, Tsai C, Liao P, Chan Y, Lee Y, et al. Aryl Hydrocarbon Receptor Defect Attenuates Mitogen-Activated Signaling through Leucine-Rich Repeats and Immunoglobulin-like Domains 1 (LRIG1)-Dependent EGFR Degradation. Int J Mol Sci. 2021;22: pubmed publisher
  7. Su S, Chen J, Jiang Y, Wang Y, Vital T, Zhang J, et al. SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth. Adv Sci (Weinh). 2021;8:e2004846 pubmed publisher
  8. Nowosad A, Creff J, Jeannot P, Culerrier R, Codogno P, Manenti S, et al. p27 controls autophagic vesicle trafficking in glucose-deprived cells via the regulation of ATAT1-mediated microtubule acetylation. Cell Death Dis. 2021;12:481 pubmed publisher
  9. Morimune T, Tano A, Tanaka Y, Yukiue H, Yamamoto T, Tooyama I, et al. Gm14230 controls Tbc1d24 cytoophidia and neuronal cellular juvenescence. PLoS ONE. 2021;16:e0248517 pubmed publisher
  10. Andrade J, Shi C, Costa A, Choi J, Kim J, Doddaballapur A, et al. Control of endothelial quiescence by FOXO-regulated metabolites. Nat Cell Biol. 2021;23:413-423 pubmed publisher
  11. Gualtieri A, Kyprianou N, Gregory L, Vignola M, Nicholson J, Tan R, et al. Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans. Nat Commun. 2021;12:2028 pubmed publisher
  12. Yin Y, Zhou N, Zhang H, Dai X, Lv X, Chen N, et al. Bmi1 regulate tooth and mandible development by inhibiting p16 signal pathway. J Cell Mol Med. 2021;25:4195-4203 pubmed publisher
  13. Lee J, Park I, Kwak M, Rhee W, Kim S, Shin J. HMGB1 orchestrates STING-mediated senescence via TRIM30α modulation in cancer cells. Cell Death Discov. 2021;7:28 pubmed publisher
  14. Qiao F, Law H, Krieger K, Clement E, Xiao Y, Buckley S, et al. Ctdp1 deficiency leads to early embryonic lethality in mice and defects in cell cycle progression in MEFs. Biol Open. 2021;10: pubmed publisher
  15. Zatulovskiy E, Zhang S, Berenson D, Topacio B, Skotheim J. Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division. Science. 2020;369:466-471 pubmed publisher
  16. Zhang J, Huang J, Zhang Y, Zhang X, Zhao L, Li C, et al. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. EBioMedicine. 2020;53:102701 pubmed publisher
  17. Cui J, Duan J, Chu J, Guo C, Xi M, Li Y, et al. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway. Aging (Albany NY). 2020;12:1591-1609 pubmed publisher
  18. Xue J, Zhao Y, Aronowitz J, Mai T, Vides A, Qeriqi B, et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature. 2020;577:421-425 pubmed publisher
  19. Guiley K, Stevenson J, Lou K, Barkovich K, Kumarasamy V, Wijeratne T, et al. p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition. Science. 2019;366: pubmed publisher
  20. Pickering J, Chinnaiya K, Towers M. An autoregulatory cell cycle timer integrates growth and specification in chick wing digit development. elife. 2019;8: pubmed publisher
  21. Sin Chan P, Mumal I, Suwal T, Ho B, Fan X, Singh I, et al. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor. Cancer Cell. 2019;36:51-67.e7 pubmed publisher
  22. Kaur S, Nag A, Gangenahalli G, Sharma K. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Front Genet. 2019;10:554 pubmed publisher
  23. Walter D, Yates T, Ruiz Torres M, Kim Kiselak C, Gudiel A, Deshpande C, et al. RB constrains lineage fidelity and multiple stages of tumour progression and metastasis. Nature. 2019;569:423-427 pubmed publisher
  24. Lawton A, Engstrom T, Rohrbach D, Omura M, Turnbull D, Mamou J, et al. Cerebellar folding is initiated by mechanical constraints on a fluid-like layer without a cellular pre-pattern. elife. 2019;8: pubmed publisher
  25. Ding L, Shunkwiler L, Harper N, Zhao Y, Hinohara K, Huh S, et al. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment. PLoS Genet. 2019;15:e1008002 pubmed publisher
  26. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed publisher
  27. Wang D, Xu Q, Yuan Q, Jia M, Niu H, Liu X, et al. Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab. Oncogene. 2019;38:3458-3474 pubmed publisher
  28. Wang M, Tang C, Xing R, Liu X, Han X, Liu Y, et al. WDR81 regulates adult hippocampal neurogenesis through endosomal SARA-TGFβ signaling. Mol Psychiatry. 2018;: pubmed publisher
  29. Chen X, Chanda A, Ikeuchi Y, Zhang X, Goodman J, Reddy N, et al. The Transcriptional Regulator SnoN Promotes the Proliferation of Cerebellar Granule Neuron Precursors in the Postnatal Mouse Brain. J Neurosci. 2019;39:44-62 pubmed publisher
  30. Wang J, Wang F, Zhu J, Song M, An J, Li W. Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. J Mol Neurosci. 2018;65:102-109 pubmed publisher
  31. Xu B, Deng Y, Bi R, Guo H, Shu C, Shah N, et al. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification. Cancer Chemother Pharmacol. 2018;81:1083-1093 pubmed publisher
  32. Xiao G, Chan L, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484.e18 pubmed publisher
  33. Shen L, Qu X, Li H, Xu C, Wei M, Wang Q, et al. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis. Oncogene. 2018;37:1759-1774 pubmed publisher
  34. Fang J, Coon B, Gillis N, Chen Z, Qiu J, Chittenden T, et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat Commun. 2017;8:2149 pubmed publisher
  35. Haricharan S, Punturi N, Singh P, Holloway K, Anurag M, Schmelz J, et al. Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. Cancer Discov. 2017;7:1168-1183 pubmed publisher
  36. Zhou Y, Huang T, Zhang J, Wong C, Zhang B, Dong Y, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518-6530 pubmed publisher
  37. Lang M, Jenkins S, Balzano P, Owoyele A, Patel A, Bamezai A. Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4+ T-cell lines. Immun Inflamm Dis. 2017;5:448-460 pubmed publisher
  38. Wang Q, Yu Y, Zhang P, Chen Y, Li C, Chen J, et al. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Basic Res Cardiol. 2017;112:47 pubmed publisher
  39. He D, Ren B, Liu S, Tan L, Cieply K, Tseng G, et al. Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies. Oncogene. 2017;36:3629-3639 pubmed publisher
  40. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  41. Feng W, Kawauchi D, Körkel Qu H, Deng H, Serger E, Sieber L, et al. Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme. Nat Commun. 2017;8:14758 pubmed publisher
  42. Po A, Begalli F, Abballe L, Alfano V, Besharat Z, Catanzaro G, et al. ?-Arrestin1/miR-326 Transcription Unit Is Epigenetically Regulated in Neural Stem Cells Where It Controls Stemness and Growth Arrest. Stem Cells Int. 2017;2017:5274171 pubmed publisher
  43. Jeannot P, Nowosad A, Perchey R, Callot C, Bennana E, Katsube T, et al. p27Kip1 promotes invadopodia turnover and invasion through the regulation of the PAK1/Cortactin pathway. elife. 2017;6: pubmed publisher
  44. Tormos A, Rius Pérez S, Jorques M, Rada P, Ramírez L, Valverde A, et al. p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging. PLoS ONE. 2017;12:e0171738 pubmed publisher
  45. Graziano A, Cardile V, Avola R, Vicario N, Parenti C, Salvatorelli L, et al. Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation. Oncotarget. 2017;8:13917-13931 pubmed publisher
  46. Xu J, Zhou W, Yang F, Chen G, Li H, Zhao Y, et al. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor. Nat Commun. 2017;8:14002 pubmed publisher
  47. Kim H, Lee S, Kim C, Kim Y, Ju W, Kim S. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells. Oncotarget. 2017;8:6608-6622 pubmed publisher
  48. Ishikawa Y, Gamo K, Yabuki M, Takagi S, Toyoshima K, Nakayama K, et al. A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells. Mol Cancer Ther. 2017;16:273-284 pubmed publisher
  49. Cramer S, Saha A, Liu J, Tadi S, Tiziani S, Yan W, et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat Med. 2017;23:120-127 pubmed publisher
  50. Brocks T, Fedorchenko O, Schliermann N, Stein A, Moll U, Seegobin S, et al. Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin. FASEB J. 2017;31:526-543 pubmed publisher
  51. Fujimura K, Mitsuhashi T, Shibata S, Shimozato S, Takahashi T. In Utero Exposure to Valproic Acid Induces Neocortical Dysgenesis via Dysregulation of Neural Progenitor Cell Proliferation/Differentiation. J Neurosci. 2016;36:10908-10919 pubmed
  52. Schlierf A, Altmann E, Quancard J, Jefferson A, Assenberg R, Renatus M, et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun. 2016;7:13166 pubmed publisher
  53. Qi D, Cobrinik D. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene. 2017;36:1760-1769 pubmed publisher
  54. Uematsu K, Okumura F, Tonogai S, Joo Okumura A, Alemayehu D, Nishikimi A, et al. ASB7 regulates spindle dynamics and genome integrity by targeting DDA3 for proteasomal degradation. J Cell Biol. 2016;215:95-106 pubmed
  55. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  56. Jayapal S, Ang H, Wang C, Bisteau X, Caldez M, Xuan G, et al. Cyclin A2 regulates erythrocyte morphology and numbers. Cell Cycle. 2016;15:3070-3081 pubmed
  57. Chen P, Qin L, Li G, Tellides G, Simons M. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF?)-dependent smooth muscle cell phenotype modulation. Sci Rep. 2016;6:33407 pubmed publisher
  58. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed publisher
  59. Jinesh G, Molina J, Huang L, Laing N, Mills G, Bar Eli M, et al. Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis. Cell Death Discov. 2016;2:16003 pubmed publisher
  60. Xue C, Yu D, Gherardi S, Koach J, Milazzo G, Gamble L, et al. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4. Oncotarget. 2016;7:54937-54951 pubmed publisher
  61. Mo Z, Zhang Q, Liu Z, Lauer J, Shi Y, Sun L, et al. Neddylation requires glycyl-tRNA synthetase to protect activated E2. Nat Struct Mol Biol. 2016;23:730-7 pubmed publisher
  62. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  63. Esmaeili M, Pungsrinont T, Schaefer A, Baniahmad A. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling. J Mol Med (Berl). 2016;94:1167-1179 pubmed
  64. Chen P, Qin L, Li G, Tellides G, Simons M. Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression. EMBO Mol Med. 2016;8:712-28 pubmed publisher
  65. Chen R, Liu H, Cheng Q, Jiang B, Peng R, Zou Q, et al. MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide. Biol Open. 2016;5:669-77 pubmed publisher
  66. Ferrán B, Martí Pàmies I, Alonso J, Rodríguez Calvo R, Aguiló S, Vidal F, et al. The nuclear receptor NOR-1 regulates the small muscle protein, X-linked (SMPX) and myotube differentiation. Sci Rep. 2016;6:25944 pubmed publisher
  67. Yang Y, Lu Y, Wang L, Mizokami A, Keller E, Zhang J, et al. Skp2 is associated with paclitaxel resistance in prostate cancer cells. Oncol Rep. 2016;36:559-66 pubmed publisher
  68. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun. 2016;7:11471 pubmed publisher
  69. Moshfegh C, Aires L, Kisielow M, Vogel V. A gonogenic stimulated transition of mouse embryonic stem cells with enhanced control of diverse differentiation pathways. Sci Rep. 2016;6:25104 pubmed publisher
  70. Zhuang L, Yang Y, Ma X, Han B, Wang Z, Zhao Q, et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203 pubmed publisher
  71. Martínez M, Ubeda A, Moreno J, Trillo M. Power Frequency Magnetic Fields Affect the p38 MAPK-Mediated Regulation of NB69 Cell Proliferation Implication of Free Radicals. Int J Mol Sci. 2016;17:510 pubmed publisher
  72. Negis Y, Karabay A. Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity. Biofactors. 2016;42:358-67 pubmed publisher
  73. Yan B, Zhang Z, Jin D, Cai C, Jia C, Liu W, et al. mTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation. Nat Commun. 2016;7:11151 pubmed publisher
  74. Yoshikawa M, Ouji Y. Induction of Inner Ear Hair Cells from Mouse Embryonic Stem Cells In Vitro. Methods Mol Biol. 2016;1516:257-267 pubmed publisher
  75. Cao C, Wang Z, Huang L, Bai L, Wang Y, Liang Y, et al. Down-regulation of tumor endothelial marker 8 suppresses cell proliferation mediated by ERK1/2 activity. Sci Rep. 2016;6:23419 pubmed publisher
  76. Zhao H, Wang H, Bauzon F, Lu Z, Fu H, Cui J, et al. Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis. J Biol Chem. 2016;291:10201-9 pubmed publisher
  77. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  78. Pavlides S, Lecanda J, Daubriac J, Pandya U, Gama P, Blank S, et al. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth. Cell Cycle. 2016;15:931-47 pubmed publisher
  79. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  80. Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, et al. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications. Mol Cancer Ther. 2016;15:628-39 pubmed publisher
  81. Singh A, Joshi S, Zulcic M, Alcaraz M, GARLICH J, Morales G, et al. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma. PLoS ONE. 2016;11:e0150836 pubmed publisher
  82. Cho C, Lee K, Chen W, Wang C, Chang Y, Huang H, et al. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer. Oncotarget. 2016;7:14586-604 pubmed publisher
  83. Podmirseg S, Jäkel H, Ranches G, Kullmann M, Sohm B, Villunger A, et al. Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion. Oncogene. 2016;35:4580-90 pubmed publisher
  84. Couderc C, Boin A, Fuhrmann L, Vincent Salomon A, Mandati V, Kieffer Y, et al. AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin. Neoplasia. 2016;18:10-24 pubmed publisher
  85. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  86. Berges C, Chatterjee M, Topp M, Einsele H. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Immunol Res. 2016;64:687-98 pubmed publisher
  87. Ding X, Jiang W, Zhou P, Liu L, Wan X, Yuan X, et al. Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7). PLoS ONE. 2015;10:e0145023 pubmed publisher
  88. Lyu L, Whitcomb E, Jiang S, Chang M, Gu Y, Duncan M, et al. Unfolded-protein response-associated stabilization of p27(Cdkn1b) interferes with lens fiber cell denucleation, leading to cataract. FASEB J. 2016;30:1087-95 pubmed publisher
  89. Yu D, Makkar G, Dong T, Strickland D, Sarkar R, Monahan T. MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism. PLoS ONE. 2015;10:e0141397 pubmed publisher
  90. Kapoor I, Kanaujiya J, Kumar Y, Thota J, Bhatt M, Chattopadhyay N, et al. Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation. Oncotarget. 2016;7:7640-56 pubmed publisher
  91. Qin J, Zhou Z, Chen W, Wang C, Zhang H, Ge G, et al. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5. Nat Commun. 2015;6:8471 pubmed publisher
  92. Chiang K, Chen H, Hsu S, Pang J, Wang S, Hsu J, et al. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo. Drug Des Devel Ther. 2015;9:4631-8 pubmed publisher
  93. Yan G, Wang Q, Hu S, Wang D, Qiao Y, Ma G, et al. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury. Int J Mol Med. 2015;36:1001-11 pubmed publisher
  94. Zhou N, Yuan S, Wang R, Zhang W, Chen J. Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence. Oncotarget. 2015;6:30745-61 pubmed publisher
  95. Bornstein G, Grossman C. COP9-Signalosome deneddylase activity is enhanced by simultaneous neddylation: insights into the regulation of an enzymatic protein complex. Cell Div. 2015;10:5 pubmed publisher
  96. Golden E, Benito Gonzalez A, Doetzlhofer A. The RNA-binding protein LIN28B regulates developmental timing in the mammalian cochlea. Proc Natl Acad Sci U S A. 2015;112:E3864-73 pubmed publisher
  97. Preuße K, Tveriakhina L, Schuster Gossler K, Gaspar C, Rosa A, Henrique D, et al. Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo. PLoS Genet. 2015;11:e1005328 pubmed publisher
  98. Ge F, Chen W, Qin J, Zhou Z, Liu R, Liu L, et al. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5). Oncotarget. 2015;6:21369-78 pubmed
  99. Orlando S, Gallastegui E, Besson A, Abril G, Aligué R, Pujol M, et al. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes. Nucleic Acids Res. 2015;43:6860-73 pubmed publisher
  100. Zuckermann M, Hovestadt V, Knobbe Thomsen C, Zapatka M, Northcott P, Schramm K, et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun. 2015;6:7391 pubmed publisher
  101. Xie C, Wei D, Zhao L, Marchetto S, Mei L, Borg J, et al. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J Cell Biol. 2015;209:721-37 pubmed publisher
  102. Wang C, Nie Z, Zhou Z, Zhang H, Liu R, Wu J, et al. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1. Oncotarget. 2015;6:17685-97 pubmed
  103. Benzina S, Pitaval A, Lemercier C, Lustremant C, Frouin V, Wu N, et al. A kinome-targeted RNAi-based screen links FGF signaling to H2AX phosphorylation in response to radiation. Cell Mol Life Sci. 2015;72:3559-73 pubmed publisher
  104. Xu D, Li C, Zhang X, Gong Z, Chan C, Lee S, et al. Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis. Nat Commun. 2015;6:6641 pubmed publisher
  105. Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed publisher
  106. Yanagi T, Shi R, Aza Blanc P, Reed J, Matsuzawa S. PCTAIRE1-knockdown sensitizes cancer cells to TNF family cytokines. PLoS ONE. 2015;10:e0119404 pubmed publisher
  107. Vogel C, Smit M, Maddalo G, Possik P, Sparidans R, van der Burg S, et al. Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res. 2015;28:307-17 pubmed publisher
  108. van der Laden J, Soppa U, Becker W. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK). Cell Commun Signal. 2015;13:3 pubmed publisher
  109. Urness L, Wang X, Shibata S, Ohyama T, Mansour S. Fgf10 is required for specification of non-sensory regions of the cochlear epithelium. Dev Biol. 2015;400:59-71 pubmed publisher
  110. Xia J, Chen S, Lv Y, Lu L, Hu W, Zhou Y. ZGDHu-1 induces Gâ‚‚/M phase arrest and apoptosis in Kasumi-1 cells. Mol Med Rep. 2015;11:3398-404 pubmed publisher
  111. Li P, Wu J, Zheng J, Pei D. A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells. Asian Pac J Cancer Prev. 2014;15:10381-5 pubmed
  112. Myklebust L, Van Damme P, Støve S, Dörfel M, Abboud A, Kalvik T, et al. Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects. Hum Mol Genet. 2015;24:1956-76 pubmed publisher
  113. Pickholtz I, Saadyan S, Keshet G, Wang V, Cohen R, Bouwman P, et al. Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells. Oncotarget. 2014;5:11827-46 pubmed
  114. Peterson E, Menon V, Gatti L, Kipping R, Dewasinghe D, Perego P, et al. Nucleolar targeting by platinum: p53-independent apoptosis follows rRNA inhibition, cell-cycle arrest, and DNA compaction. Mol Pharm. 2015;12:287-97 pubmed publisher
  115. Chen J, Shin J, Zhao R, Phan L, Wang H, Xue Y, et al. CSN6 drives carcinogenesis by positively regulating Myc stability. Nat Commun. 2014;5:5384 pubmed publisher
  116. Kim M, Kim M, Lee M, Kim C, Lim D. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis. Nat Commun. 2014;5:5370 pubmed publisher
  117. Perry M, Dufour C, Eichner L, Tsang D, Deblois G, Muller W, et al. ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction. Mol Cell Biol. 2014;34:4232-43 pubmed publisher
  118. Yanagi T, Krajewska M, Matsuzawa S, Reed J. PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells. Cancer Res. 2014;74:5795-807 pubmed publisher
  119. Nishimura Y, Shikanai M, Hoshino M, Ohshima T, Nabeshima Y, Mizutani K, et al. Cdk5 and its substrates, Dcx and p27kip1, regulate cytoplasmic dilation formation and nuclear elongation in migrating neurons. Development. 2014;141:3540-50 pubmed publisher
  120. Oliveira C, de Bock C, Molloy T, Sadeqzadeh E, Geng X, Hersey P, et al. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma. BMC Cancer. 2014;14:630 pubmed publisher
  121. Wojdyla L, Stone A, Sethakorn N, Uppada S, Devito J, Bissonnette M, et al. T-oligo as an anticancer agent in colorectal cancer. Biochem Biophys Res Commun. 2014;446:596-601 pubmed publisher
  122. Kim J, Kim H, Park J, Park D, Cho Y, Sohn C, et al. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells. World J Gastroenterol. 2014;20:755-73 pubmed publisher
  123. Douthwright S, Sluder G. Link between DNA damage and centriole disengagement/reduplication in untransformed human cells. J Cell Physiol. 2014;229:1427-36 pubmed publisher
  124. Fiori M, Barbini C, Haas T, Marroncelli N, Patrizii M, Biffoni M, et al. Antitumor effect of miR-197 targeting in p53 wild-type lung cancer. Cell Death Differ. 2014;21:774-82 pubmed publisher
  125. Nakayama A, Nakayama M, Turner C, Höing S, Lepore J, Adams R. Ephrin-B2 controls PDGFR? internalization and signaling. Genes Dev. 2013;27:2576-89 pubmed publisher
  126. van Boxtel R, Gomez Puerto C, Mokry M, Eijkelenboom A, van der Vos K, Nieuwenhuis E, et al. FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis. Cell Death Differ. 2013;20:1219-29 pubmed publisher
  127. Moreno A, Soleto I, García Sanz P, Moreno Bueno G, Palmero I. ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth. Oncogene. 2014;33:1945-53 pubmed publisher
  128. Shirazi Fard S, Jarrin M, Boije H, Fillon V, All Eriksson C, Hallböök F. Heterogenic final cell cycle by chicken retinal Lim1 horizontal progenitor cells leads to heteroploid cells with a remaining replicated genome. PLoS ONE. 2013;8:e59133 pubmed publisher
  129. Caldon C, Sergio C, Burgess A, Deans A, Sutherland R, Musgrove E. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1. Cell Cycle. 2013;12:606-17 pubmed publisher
  130. Perez Sanz J, Arluzea J, Matorras R, González Santiago N, Bilbao J, Yeh N, et al. Increased number of multi-oocyte follicles (MOFs) in juvenile p27Kip1 mutant mice: potential role of granulosa cells. Hum Reprod. 2013;28:1023-30 pubmed publisher
  131. Chen S, Fu S, Hsu S, Huang Y, Hsu B. Synergistic Effect of Hyperglycemia and p27(kip1) Suppression on Adult Mouse Islet Beta Cell Replication. Int J Endocrinol. 2012;2012:417390 pubmed publisher
  132. Diril M, Ratnacaram C, Padmakumar V, Du T, Wasser M, Coppola V, et al. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc Natl Acad Sci U S A. 2012;109:3826-31 pubmed publisher
  133. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  134. Macia A, Gallel P, Vaquero M, Gou Fabregas M, Santacana M, Maliszewska A, et al. Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma. Oncogene. 2012;31:3961-72 pubmed publisher
  135. Inaki M, Kato D, Utsugi T, Onoda F, Hanaoka F, Murakami Y. Genetic analyses using a mouse cell cycle mutant identifies magoh as a novel gene involved in Cdk regulation. Genes Cells. 2011;16:166-78 pubmed publisher
  136. Martín Ibáñez R, Crespo E, Urbán N, Sergent Tanguy S, Herranz C, Jaumot M, et al. Ikaros-1 couples cell cycle arrest of late striatal precursors with neurogenesis of enkephalinergic neurons. J Comp Neurol. 2010;518:329-51 pubmed publisher
  137. Hagihara K, Zhang E, Ke Y, Liu G, Liu J, Rao Y, et al. Shp2 acts downstream of SDF-1alpha/CXCR4 in guiding granule cell migration during cerebellar development. Dev Biol. 2009;334:276-84 pubmed publisher
  138. Poche R, Furuta Y, Chaboissier M, Schedl A, Behringer R. Sox9 is expressed in mouse multipotent retinal progenitor cells and functions in Müller glial cell development. J Comp Neurol. 2008;510:237-50 pubmed publisher
  139. James M, Ray A, Leznova D, Blain S. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. Mol Cell Biol. 2008;28:498-510 pubmed
  140. Jones L, Tilli M, Assefnia S, Torre K, Halama E, Parrish A, et al. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene. 2008;27:794-802 pubmed
  141. Elshatory Y, Deng M, Xie X, Gan L. Expression of the LIM-homeodomain protein Isl1 in the developing and mature mouse retina. J Comp Neurol. 2007;503:182-97 pubmed
  142. Seminario M, Precht P, Wersto R, Gorospe M, Wange R. PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression. Oncogene. 2003;22:8195-204 pubmed